Altimmune, Inc. announced that its board of directors appointed Diane Jorkasky, M.D. as a member of the Board. At the time of her appointment, committee membership for Dr. Jorkasky had not yet been determined. The Company hereby amends Item 5.02 of the Form 8-K to report that on July 11, 2020, the Board, upon the recommendation of the company's Nominating and Corporate Governance Committee, appointed Dr. Jorkasky as a member of the Board's Compensation Committee.